TREML4 Activators

TREML4, or Triggering Receptor Expressed On Myeloid Cells Like 4, is a gene encoding a protein that belongs to the triggering receptor expressed on myeloid cells (TREM) family. This family comprises receptors expressed primarily on the surfaces of immune cells, particularly those of the myeloid lineage such as monocytes, macrophages, and dendritic cells.The TREML4 protein is a type 1 membrane receptor, characterized by an extracellular immunoglobulin-like domain. It is involved in the modulation of immune responses, although its specific functions and ligands are still being explored. As with other TREM family members, TREML4 is thought to play a role in the innate immune system, which serves as the body's first line of defense against pathogens.

Innate immune receptors like TREML4 are crucial for recognizing pathogen-associated molecular patterns (PAMPs) and initiating immune responses. This involves activating signaling pathways that lead to the production of inflammatory cytokines, chemokines, and other mediators necessary for combating infections.Studies have suggested that TREML4 might be involved in the regulation of inflammation. It may influence the activity of other immune cells, playing a role in inflammatory diseases, autoimmune disorders, and the immune response to infections.The expression of TREML4 is also of interest in the context of diseases such as atherosclerosis, where immune responses and inflammation play key roles. Understanding the function of TREML4 in these processes could provide insights into the mechanisms of such diseases.